Meloxicam Teva

Meloxicam, the active ingredient in Meloxicam Teva, is an Oxicam (NSAID) presented as an oral tablet for oral use. It treats pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal conditions. It is commonly prescribed for chronic inflammatory joint diseases and for short‑term relief of acute pain.

GNH USA supplies Meloxicam Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable global logistics.

Meloxicam acts on inflammatory pathways in musculoskeletal disorders, providing analgesic and anti‑inflammatory effects.

- Osteoarthritis: reduces joint pain and swelling, improving function. - Rheumatoid arthritis: alleviates pain and inflammation, helping control disease activity. - Ankylosing spondylitis: diminishes spinal pain and stiffness. - Acute musculoskeletal pain: provides rapid relief of pain and inflammation from injuries or overuse.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia. - Nausea or vomiting. - Headache. - Dizziness. - Peripheral edema. - Elevated liver enzymes.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Severe skin reactions, including Stevens‑Johnson syndrome. - Hepatic failure or severe liver injury. - Acute renal impairment or failure. - Anaphylactic or severe hypersensitivity reactions.

When prescribing meloxicam, clinicians should consider several safety aspects.

- Renal function: monitor in patients with existing kidney disease. - Cardiovascular risk: use cautiously in patients with history of heart disease or stroke. - Gastrointestinal safety: assess risk of ulcer or bleeding, especially with concurrent NSAIDs or anticoagulants. - Pregnancy and lactation: avoid unless benefits outweigh risks, as safety category is unknown. - Concomitant medications: review for potential interactions, particularly with anticoagulants, diuretics, lithium, methotrexate. - Store at ambient temperature: keep below 25°C, protect from moisture and light in original packaging.

Meloxicam can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective COX‑2 inhibitors: additive cardiovascular risk. - Lithium: increased serum lithium levels. - Methotrexate: enhanced toxicity. - Cyclosporine: increased nephrotoxicity.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal clearance of meloxicam. - ACE inhibitors or ARBs: potential for reduced renal function. - SSRIs or SNRIs: heightened bleeding tendency. - Beta‑blockers: possible reduced antihypertensive effect. - Alcohol: may increase gastrointestinal irritation.